Martin Hersberger Selected Research

Reperfusion Injury

1/2014	The mechanism of Intralipid®-mediated cardioprotection complex IV inhibition by the active metabolite, palmitoylcarnitine, generates reactive oxygen species and activates reperfusion injury salvage kinases.
1/2014	Loss of Intralipid®- but not sevoflurane-mediated cardioprotection in early type-2 diabetic hearts of fructose-fed rats: importance of ROS signaling.
2/2013	Infarct-remodelled hearts with limited oxidative capacity boost fatty acid oxidation after conditioning against ischaemia/reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Hersberger Research Topics

Disease

25	Inflammation (Inflammations) 01/2022 - 06/2004
11	Atherosclerosis 04/2014 - 06/2004
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2012 - 01/2005
5	Insulin Resistance 01/2021 - 09/2009
4	Myocardial Infarction 01/2014 - 03/2005
4	Infections 05/2009 - 08/2006
3	Heart Failure 01/2022 - 07/2007
3	Acute Coronary Syndrome 01/2014 - 04/2007
3	Reperfusion Injury 01/2014 - 02/2013
3	Disease Progression 03/2013 - 04/2004
3	Coronary Disease (Coronary Heart Disease) 03/2005 - 01/2003
2	Epilepsy (Aura) 01/2020 - 01/2016
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 08/2006
2	Ischemia 07/2018 - 01/2014
2	Inborn Errors Metabolism (Inborn Errors of Metabolism) 01/2016 - 01/2003
2	Atherosclerotic Plaque (Atheroma) 04/2014 - 07/2011
2	Unstable Angina 01/2014 - 07/2007
2	Heart Diseases (Heart Disease) 09/2011 - 01/2010
2	Iron Overload 07/2010 - 08/2006
2	Hemochromatosis (Bronze Diabetes) 07/2010 - 08/2006
2	Chronic Renal Insufficiency 05/2010 - 07/2007
2	Kidney Diseases (Kidney Disease) 05/2010 - 07/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2010 - 06/2004
2	Disorders of Excessive Somnolence (Hypersomnia) 01/2010 - 08/2006
2	Pulmonary Hypertension 01/2010 - 01/2010
2	Diabetes Mellitus 03/2007 - 06/2004
1	Hypotension (Low Blood Pressure) 05/2022
1	Hemolysis 02/2022
1	Atrophy 01/2022
1	Neoplasms (Cancer) 01/2022
1	Dysbiosis 01/2022
1	Neuroinflammatory Diseases 04/2021
1	Major Depressive Disorder (Major Depressive Disorders) 04/2021
1	Hyperinsulinism (Hyperinsulinemia) 01/2021
1	Congenital Abnormalities (Deformity) 01/2021

Drug/Important Bio-Agent (IBA)

14	LipidsIBA 10/2021 - 06/2004
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2007
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 06/2004
5	Insulin (Novolin)FDA Link 01/2021 - 06/2004
5	Proteins (Proteins, Gene)FDA Link 01/2016 - 03/2007
5	CholesterolIBA 10/2013 - 06/2004
5	CytokinesIBA 03/2013 - 06/2004
5	HDL CholesterolIBA 09/2009 - 01/2003
4	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 04/2014 - 08/2007
4	Apolipoproteins E (ApoE)IBA 03/2013 - 11/2004
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 07/2007
3	EmulsionsIBA 01/2021 - 02/2015
3	EnzymesIBA 01/2019 - 08/2010
3	Neutralizing AntibodiesIBA 03/2013 - 09/2004
3	CreatinineIBA 05/2010 - 05/2007
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2005
2	resolvin D1IBA 11/2021 - 04/2016
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 04/2021 - 01/2021
2	phospholipid emulsion soybean oil (Intralipid)IBA 01/2021 - 02/2015
2	IncretinsIBA 01/2021 - 01/2021
2	OxysterolsIBA 01/2019 - 06/2015
2	Messenger RNA (mRNA)IBA 01/2019 - 11/2012
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2016 - 01/2010
2	Phosphotransferases (Kinase)IBA 12/2014 - 01/2014
2	LipoxygenasesIBA 04/2014 - 11/2012
2	FructoseIBA 03/2014 - 01/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014 - 03/2007
2	InflammasomesIBA 10/2013 - 07/2011
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 03/2013 - 10/2006
2	VaccinesIBA 03/2013 - 09/2004
2	InterleukinsIBA 03/2013 - 07/2011
2	Triglycerides (Triacylglycerol)IBA 02/2013 - 09/2009
2	oxidized low density lipoproteinIBA 11/2012 - 09/2009
2	Interleukin-4 (Interleukin 4)IBA 11/2012 - 11/2010
2	lipoxin A4IBA 02/2012 - 01/2012
2	ApolipoproteinsIBA 07/2011 - 10/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2010 - 08/2006
2	LipoxinsIBA 08/2010 - 01/2007
2	Biological ProductsIBA 08/2010 - 09/2009
2	IronIBA 07/2010 - 08/2006
2	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 05/2010 - 08/2006
2	Serotonin (5 Hydroxytryptamine)IBA 01/2010 - 01/2010
2	OrexinsIBA 01/2010 - 09/2006
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 03/2005 - 06/2004
2	C-Reactive ProteinIBA 03/2005 - 06/2004
2	Protective AgentsIBA 03/2005 - 06/2004
2	HDL LipoproteinsIBA 06/2004 - 01/2003
1	Arginine Vasopressin (Argipressin)IBA 05/2022
1	Hemoglobins (Hemoglobin)IBA 02/2022
1	Troponin T (Troponin T1)IBA 01/2022
1	Collagen Type I (Type I Collagen)IBA 01/2022
1	Collagen Type III (Type III Collagen)IBA 01/2022
1	collagen type I trimeric cross-linked peptideIBA 01/2022
1	Growth Differentiation Factor 15IBA 01/2022
1	Galectin 3 (LGALS3)IBA 01/2022
1	EndocannabinoidsIBA 04/2021
1	Bile Acids and Salts (Bile Acids)IBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Phytosterols (Plant Sterols)IBA 01/2021
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021

Therapy/Procedure

3	Total Parenteral Nutrition 01/2022 - 01/2021
2	Therapeutics 12/2014 - 08/2006
1	Immunomodulation 04/2021